Usually, MpBC does not express ER, PR, or HER2; thus, it can often be evaluated as a subgroup of triple-negative breast cancer (TNBC), considering its immunohistochemical characteristics [29]. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.